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Programmed necrosis, like apoptosis, eliminates
pathogen-infected cells as a component of host
defense. Receptor-interacting protein kinase (RIP) 3
(also called RIPK3) mediates RIP homotypic interac-
tion motif (RHIM)-dependent programmed necrosis
induced by murine cytomegalovirus (MCMV) infec-
tion or death receptor activation and suppressed
by the MCMV-encoded viral inhibitor of RIP activa-
tion (vIRA). We find that interferon-independent
expression of DNA-dependent activator of interferon
regulatory factors (DAI, also known as ZBP1 or
DLM-1) sensitizes cells to virus-induced necrosis
and that DAI knockdown or knockout cells are resis-
tant to this death pathway. Importantly, as with
RIP3/ mice, vIRA mutant MCMV pathogenesis is
restored in DAI/ mice, consistent with a DAI-RIP3
complex being the natural target of vIRA. Thus, DAI
interacts with RIP3 to mediate virus-induced necro-
sis analogous to the RIP1-RIP3 complex controlling
death receptor-induced necroptosis. These studies
unveil a role for DAI as the RIP3 partner mediating
virus-induced necrosis.
INTRODUCTION
Programmed cell death may be triggered to cut short viral infec-
tion and can be targeted by pathogen-encoded cell death
suppressors (Best, 2008; Lamkanfi and Dixit, 2010). Apoptosis
is a well-recognized caspase-dependent host defense pathway
triggered through cell-intrinsic as well as cell-extrinsic signals
that also helps shape embryonic development (Hengartner,
2000; Strasser et al., 2000). Recent insights have revealed pro-
grammed necrotic cell death to be an important alternate host
defense pathway (Cho et al., 2009; Upton et al., 2010). The
cellular protein kinase RIP3 plays a central role in transducing
signals that drive programmed necrosis whether induced by
death receptor (DR) or pattern recognition receptor (PRR) activa-
tion (He et al., 2009, 2011; Zhang et al., 2009), during develop-
ment (Kaiser et al., 2011; Oberst et al., 2011), or in the course290 Cell Host & Microbe 11, 290–297, March 15, 2012 ª2012 Elsevieof viral infection (Cho et al., 2009; Upton et al., 2010). DR-
induced programmed necrosis, also called necroptosis, is re-
vealed whenever caspase-8 activity is compromised, and
requires formation of a RHIM-dependent RIP1-RIP3 complex
(necrosome) and the kinase activity of both (Cho et al., 2009;
He et al., 2009; Mocarski et al., 2011; Upton et al., 2010; Zhang
et al., 2009).
MCMV-encoded viral inhibitor of RIP activation (vIRA), the
product of the M45 gene, is a potent RHIM-containing cell death
suppressor (Brune et al., 2001; Mack et al., 2008; Upton et al.,
2008, 2010). vIRA has the capacity to inhibit DR- or TIR-
domain-containing adaptor-inducing IFNb (TRIF)-dependent
apoptosis, necroptosis, and virus-induced programmed
necrosis (Mack et al., 2008; Upton et al., 2008, 2010) as well
as NF-kB activation and RIP3 autophosphorylation induced by
overexpression of the PRR DAI (Rebsamen et al., 2009). The
natural role of vIRA is to prevent rapid RIP3-dependent necrosis
over the initial 8–12 hr of infection (Upton et al., 2008, 2010).
Importantly, viruses that lack vIRA, or that encode a tetra-alanine
RHIM substitution (M45mutRHIM), are severely attenuated in
mice (Lembo et al., 2004; Upton et al., 2010). The significance
of programmed necrosis as a bona fide host defense pathway
was highlighted by complete normalization of vIRA RHIMmutant
virus pathogenesis in RIP3-deficient mice (Upton et al., 2010).
MCMV vIRA thereby illuminated a RHIM-dependent death
pathway functioning alongside apoptosis in mammalian host
defense (Mocarski et al., 2011).
Whereas DR-induced necroptosis relies on a RHIM-depen-
dent RIP1-RIP3 signaling complex, virus-induced necrosis
follows a RIP3 RHIM-dependent pathway that is independent
of RIP1 or TRIF (Upton et al., 2008, 2010). Because RIP3 and
DAI can form a RHIM-dependent complex (Kaiser et al., 2008),
this interaction may contribute to virus-induced necrosis. DAI
is expressed constitutively in many tissues and is also IFN induc-
ible (Fu et al., 1999). As a candidate PRR triggering IFNb expres-
sion in response to cytosolic double-stranded DNA (dsDNA)
(Takaoka et al., 2007), DAI has DNA binding motifs that are
required for activation of downstream signaling and IRF3-medi-
ated gene expression (Takaoka et al., 2007;Wang et al., 2008). In
addition, DAI contains three RHIM-like repeats, one or two of
which can bind RIP3 and/or RIP1 and activate NF-kB (Kaiser
et al., 2008; Rebsamen et al., 2009). Constitutive DAI in cultured
cells induces IFNb following herpes simplex virus (HSV) (Furr
et al., 2011; Takaoka et al., 2007) or human CMV (DeFilippisr Inc.
Figure 1. RIP3 Levels Differentially Confer
Susceptibility to Necroptosis and Virus-
Induced Programmed Necrosis
(A) Immunoblot (IB) analysis to detect RIP3, RIP1,
and b-actin from NIH 3T3 cells stably expressing
33FLAG-tagged RIP3, RIP3mRHIM, or control.
(B) Viability of RIP3-expressing NIH 3T3 stable cell
lines infected with M45mutRHIM MCMV at a mul-
tiplicity of infection (moi) of 10 (n = 4).
(C) Viability of RIP3-expressing NIH 3T3 stable cell
lines after treatment with TNF (25 ng/ml) and
zVAD-fmk (50 mM) to induce necroptosis (n = 3–4).
(D) Viability of NIH 3T3, 3T3-SA, and SVEC4-10 cell
lines infected with M45mutRHIMMCMV (moi = 10)
(n = 3–7).
(E) IB analysis of uninfected NIH 3T3, 3T3-SA, and
SVEC4-10 cells to detect DAI, RIP3, RIP1, and
b-actin. A nonspecific (*ns) band is characteristic
for this antibody (Karayel et al., 2009). Error bars,
SD. **p < 0.001, #not significant (p > 0.05). See also
related Figure S1.
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DAI and RIP3 Control of Programmed Necrosiset al., 2010a; DeFilippis et al., 2010b) infection. However, based
on the phenotype of DAI/ mice, this protein has been consid-
ered ‘‘dispensable for both innate and adaptive immune
responses to B-DNA and DNA vaccine’’ (Ishii et al., 2008). Given
the impact of RIP3-dependent necrosis during MCMV infection,
together with the potential for a RHIM-dependent complex
between RIP3 and DAI (Kaiser et al., 2008), we sought to define
the role of DAI as a RIP3 partner in virus-induced necrosis.
RESULTS
RIP3 Levels Differentially Confer Susceptibility
to Necroptosis and Virus-Induced Necrosis
Because RIP3 is known to mediate virus-induced programmed
necrosis and is targeted by vIRA during infection (Upton et al.,
2010), we sought to employ sensitive (3T3-SA, SVEC4-10) and
resistant (NIH 3T3) cell lines to ask whether RIP3 was the sole
determinant of this novel death pathway (Upton et al., 2010;
Zhang et al., 2009). Introduction of WT RIP3, but not RHIM
mutant (RIP3mRHIM), into RIP3/ MEFs sensitized cells to
virus-induced necrosis (Upton et al., 2010). When naturally resis-
tant NIH 3T3 cells expressing FLAG-tagged WT RIP3, FLAG-
tagged RIP3mRHIM, or vector control (Figure 1A) were assessed
for sensitivity to programmed necrosis by infection with
M45mutRHIMMCMV or by treatment with TNF and the caspase
inhibitor, zVAD-fmk, neither WT nor mutant RIP3 was sufficient
to sensitize cells to virus-induced necrosis (Figure 1B). In
contrast, WT RIP3, but not RIP3mRHIM, sensitized NIH 3T3 cells
to TNF-induced necroptosis (Figure 1C). Thus, RIP3 levels were
not the sole determinant of virus-induced necrosis, given
that overexpression does not sensitize NIH 3T3 cells to this
death pathway under conditions in which they are sensitized
to RIP1-RIP3 necroptosis. Virus-induced necrosis requiresCell Host & Microbe 11, 290–29RHIM-dependent function of RIP3 inde-
pendent of RIP1, while necroptosis re-
quires RHIM-dependent association of
RIP1 and RIP3 (Cho et al., 2009; Heet al., 2009; Upton et al., 2010; Zhang et al., 2009). In addition,
TLR3-induced necroptosis involves RIP1 and RIP3 together
with RHIM-dependent interactions mediated by TRIF (Feoktis-
tova et al., 2011; He et al., 2011). Given the fact that neither
RIP1 nor TRIF contributes to the viral death pathway (Upton
et al., 2010), we turned attention to DAI, a constitutively ex-
pressed RHIM-containing adaptor and candidate PRR that acti-
vates NF-kB and IRF3 (Kaiser et al., 2008; Rebsamen et al.,
2009; Takaoka et al., 2007). As expected (Upton et al., 2010),
RIP3 levels were higher in necroptosis-susceptible cells and
lower in NIH 3T3 cells (Figure 1A), and RIP1 was present in all
cell lines. DAI was constitutively expressed in necrosis-sensitive
3T3-SA and SVEC4-10 cells but was not detected in necrosis-
resistant NIH 3T3 cells (Figures 1D and 1E). Importantly, both
DAI and RIP3 were present in virus-induced necrosis-sensitive
cells.
IFNb and NF-kB Signaling in Necroptosis
and Virus-Induced Necrosis
DAI is constitutively expressed as well as IFN inducible (Fu et al.,
1999), is necessary for herpesvirus-induced IFNb production
(DeFilippis et al., 2010a; Furr et al., 2011; Takaoka et al., 2007),
and is able to activate NF-kB (Kaiser et al., 2008). To assess
any potential contribution of DAI-dependent IFNb or NF-kB
signaling in virus-induced programmed necrosis, experiments
were undertaken to correlate activation events with cell death.
First, DAI was not detected in NIH 3T3 cells during MCMV infec-
tion, although IFNb treatment, as expected (Fu et al., 1999),
induced this protein within 9 hr (see Figure S1A online). Thus,
NIH 3T3 cells do not express detectable DAI during infection
even though they respond to IFNb treatment. Levels of DAI in
necrosis-sensitive 3T3-SA (Figure S1A) or SVEC4-10 (data not
shown) cells increased from 9 to 24 hr after either MCMV7, March 15, 2012 ª2012 Elsevier Inc. 291
Figure 2. Increased DAI Expression Sensitizes Resistant Cells to
Virus-Induced Necrosis
(A) IB analysis to detect FLAG and b-actin of NIH 3T3 stable cells expressing
FLAG-tagged WT DAI, FLAG-tagged DAImRHIM, or control.
(B) Viability of DAI-expressing NIH 3T3 stable cell lines infected with
M45mutRHIM MCMV (moi = 10) and treated with DMSO or Nec-1 (30 mM)
(n = 4).
(C) IB analysis to detect FLAG, RIP3, RIP1, and b-actin in stable NIH 3T3 cell
lines expressing FLAG-tagged WT DAI together with either a scramble control
(Sc) or one of two RIP3-specific shRNAs (RIP3-A or RIP3-B).
(D) Viability of DAI-expressing, RIP3 knockdown NIH 3T3 stable cell lines
following infection with M45mutRHIMMCMV (moi = 10) (n = 3). Error bars, SD.
**p < 0.001, #not significant (p > 0.05). See also related Figure S2.
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activation shown for other herpesviruses (DeFilippis et al.,
2010a, 2010b; Takaoka et al., 2007). These data suggest DAI
must be constitutively expressed in the host cell to initiate a
cell death response to MCMV infection. The same level of IFNb
mRNA is induced in SVEC4-10 cells by WT MCMV and vIRA-
deficient MCMVD45 (Brune et al., 2001) (Figure S1B), indicating
induction of IFNb is independent of vIRA under conditions in
which cell death is induced by vIRA-deficient virus (Brune
et al., 2001; Upton et al., 2008, 2010). Furthermore, DAI is
induced to comparable levels in WT and M45mutRHIM
MCMV-infected MEFs (Figure S1C). Despite the upregulation
of IFNb and DAI expression during infection with parental or
vIRA mutant virus, treatment of SVEC4-10 cells with increasing
concentrations of IFNb-neutralizing antibody did not influence
levels of virus-induced programmed necrosis (Figure S1D), indi-
cating that type I IFNs induced by infection, whether via DAI or
other PRR-dependent pathways, do not influence virus-induced
necrosis.
DAI has also been implicated as an inducer of NF-kB (Kaiser
et al., 2008; Takaoka et al., 2007). Canonical NF-kB signaling is
dispensable for MCMV infection (Benedict et al., 2004) and
does not influence necroptotic cell death (Vanden Berghe
et al., 2006). To evaluate the role of NF-kB signaling in virus-
induced necrosis, BMS-345541, a specific inhibitor of IkB kinase
(IKK) activity (Burke et al., 2003), was used to sensitize
SVEC4-10 cells to TNF-induced apoptosis (Figure S1E), indi-
cating the drug dose used here was sufficient to inhibit
NF-kB (Katdare et al., 2007). However, parallel treatment failed
to normalize the viability of SVEC4-10 cells infected with
M45mutRHIM MCMV (Figure S1F), as would be expected if
NF-kB signaling played a dominant role in this RIP3-dependent
antiviral pathway. Together, these results demonstrate that
neither IFNb nor NF-kB signaling is a major factor in virus-
induced necrotic cell death.
Introduction of DAI Sensitizes Resistant Cells
to Virus-Induced Programmed Necrosis
To determine a role for DAI in virus-induced programmed necro-
sis, NIH 3T3 cells stably expressing FLAG-tagged WT DAI,
FLAG-tagged RHIM mutant DAI (DAImRHIM, previously called
DAImRLR-A) (Kaiser et al., 2008), and empty vector control (Fig-
ure 2A) were derived. WT DAI, but not DAImRHIM, rendered
these cells susceptible to virus-induced death (Figure 2B),
results consistent with a role for RHIM-dependent interaction
between DAI and RIP3 (Kaiser et al., 2008; Rebsamen et al.,
2009). Nec-1, a potent RIP1 kinase inhibitor (Degterev et al.,
2008) that blocks TNF-induced necroptosis, fails to prevent
virus-induced programmed necrosis (Upton et al., 2010). Addi-
tionally, virus-induced necrosis was caspase independent and
did not require the action of TNF (Upton et al., 2010). Virus-
induced death in DAI-transduced NIH 3T3 cells was RIP1
kinase-independent based on resistance to Nec-1 (Figure 2B),
as well as caspase- and DR ligation independent (Figure S2).
These criteria are consistent with characteristics of virus-
induced necrosis as established previously (Upton et al., 2010).
We sought to further address the role of RIP3 by employing
specific lentivirus shRNAs to knockdown expression (Figure 2C)
in DAI-transduced NIH 3T3 cells. RIP3 now sensitized to virus-292 Cell Host & Microbe 11, 290–297, March 15, 2012 ª2012 Elsevieinduced death (Figure 2D), in contrast to nontransduced cells.
Thus, DAI and RIP3 were both required to trigger virus-induced
necrotic death. The failure of DAImRHIM to sensitize NIH 3T3
cells (Figure 2B) complements previous observations on RHIM
mutant RIP3 (Upton et al., 2010), suggesting that a RHIM-depen-
dent RIP3-DAI complex (Kaiser et al., 2008) is involved in the
death pathway. The previous demonstration that a DAI-RIP3
complex mediates NF-kB activation (Kaiser et al., 2008) that
can be inhibited by vIRA (Rebsamen et al., 2009) reinforces the
possibility this complex may be directly regulated by vIRA.
DAI-RIP3 Complex in Virus-Induced Programmed
Necrosis
We next sought to characterize whether a RIP3 and DAI interac-
tion formed during viral infection. RIP3 coimmunoprecipitated
DAI in extracts of 3T3-SA cells infected for 12 hr with vIRA
mutant MCMV, consistent with a physical interaction (Figure 3A).r Inc.
Figure 3. DAI and RIP3 Cooperate in Virus-Induced Necrosis
(A) RIP3 and DAI interaction in the absence of vIRA. IB of immunoprecipitations
(IP) and whole-cell lysates (WCL; 5% total) showing DAI, M45, RIP3, and
b-actin in 3T3-SA cells infected with M45mutRHIMMCMV (moi = 5) harvested
at the indicated times (h.p.i.).
(B) IB analysis to detect DAI, RIP3, RIP1, and b-actin in 3T3-SA cells trans-
fected with nontargeting (NT) control, DAI, or RIP3 siRNAs.
(C) Viability of 3T3-SA cells transfected with the indicated siRNA and infected
withM45mutRHIM (moi = 10) and treatedwith DMSO control or Nec-1 inhibitor
(30 mM) (n = 4).
(D) IB analysis to detect DAI, RIP3, RIP1, and b-actin in C57BL/6 control,
DAI/, and RIP3/ murine embryonic fibroblasts (MEFs).
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Cell HoExpression of RIP3 was constant, whereas levels of DAI
increased with time. Levels of the nonfunctional tetra-alanine
mutant protein expressed by M45mutRHIM MCMV increased
between 1 and 12 hpi. A DAI-RIP3 interaction could not be de-
tected during WT MCMV infection (likely a consequence of WT
vIRA activity) (Figure S3A). Given the importance of RIP3 RHIM
interactions in virus-induced necrosis (Upton et al., 2010), as
well as the known RHIM-dependent interaction between RIP3
andDAI (Kaiser et al., 2008; Rebsamen et al., 2009), these results
implicate a RIP3-DAI complex mediating programmed necrosis.
RNAi was employed in necrosis-sensitive 3T3-SA cells to
knock downDAI or RIP3 protein levels compared to nontargeting
control, while leaving RIP1 levels unchanged (Figure 3B). When
infected with mutant virus, DAI knockdown 3T3-SA cells were
protected from virus-induced necrosis at levels comparable to
those in RIP3 knockdown cells (Figure 3C). As expected, treat-
ment with RIP1 kinase inhibitor Nec-1 did not influence this
pattern of cell death. Thus, both RIP3 and DAI were necessary
to execute virus-induced programmed necrosis. Similar to
siRNA knockdown, DAI/ and RIP3/ MEFs were resistant to
virus-induced necrosis (Figures 3D and 3E), while control
(C57BL/6) MEFs remained highly sensitive (Upton et al., 2010).
Furthermore, DAI knockdown in 3T3-SA cells and DAI/
MEFs remained sensitive to TNF-induced necroptosis (Figures
S3B and S3C). Likewise, the RIP3-dependent necroptosis re-
sulting in lethality of Casp8/ mice (Kaiser et al., 2011; Oberst
et al., 2011) was not rescued by loss of DAI (Figure S3D), and
Casp8/DAI/ embryos were phenotypically indistinguishable
from Casp8/ littermate embryos (data not shown). Together,
these data indicate that loss of DAI ameliorates RIP3-dependent
virus-induced programmed necrosis without altering the
response to necroptosis requiring the RIP1-RIP3 necrosome.
To investigate the influence of DAI on virus growth, control or
DAI/ MEFs were infected and assessed for virus replication.
Parental MCMV replicated to comparable high titers in all MEF
lines tested, whereas mutant virus was attenuated in control
cells (Figure 3F, left). However, mutant virus replication was
normalized in DAI/ MEFs (Figure 3F, right), reminiscent of
normalized mutant virus growth in RIP3/ MEFs (Upton et al.,
2010). Together, these results provide evidence that RIP3 and
DAI coordinate to execute virus-induced programmed necrosis,
and that the RHIM-dependent association of RIP3 and DAI is the
natural target of MCMV vIRA.
vIRA Mutant Virus Inflammation and Replication
in DAI-Deficient Mice
To directly address the contribution of DAI to virus-induced
death, we infected DAI/ and control (C57BL/6) mice by
footpad (FP) inoculation. As in RIP3/ mice (Upton et al.,
2010), virus infection induced swelling in DAI/ mice at levels
similar to parental virus, peaking with a similar pattern to controls(E) Viability of C57BL/6 control, DAI/, and RIP3/ MEFs infected with
M45mutRHIM MCMV (moi = 10) (n = 3).
(F) Single-step replication of WT andM45mutRHIMMCMV (moi = 5) on control
C57BL/6 (left) and DAI/ (right) MEFs. Viral titers determined by plaque assay
with the first (0 hr) time point representing amount of virus in the inoculum. Error
bars, SD. *p < 0.01, **p < 0.001, #not significant (p > 0.05). See also related
Figure S3.
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Figure 4. M45mutRHIM Virus Attenuation In Vivo Is Reversed in DAI–/– Mice
(A) Footpad swelling induced by parental WT or M45mutRHIMMCMV infection. Footpad thickness of C57BL/6 control (top) and DAI/ (bottom) mice inoculated
with 106 pfu was measured with a digital caliper and mean values plotted at the indicated times over a 14 day time course (n = 7–9 animals/group).
(B–D) Viral titers from spleen (B), liver (C), and SGs (D) of control (C57BL/6), RIP3/, and DAI/ mice infected via intraperitoneal inoculation with 106 pfu of
indicated virus and harvested at the indicated time (n = 5–10 animals/group). Error bars, SEM. See also related Figure S4.
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tectible swelling in C57BL/6mice, a result expected due to atten-
uated replication (Upton et al., 2010). Thus, in the absence of
DAI, mutant virus infection patterns exhibited inflammatory char-
acteristics of WT MCMV infection, strongly supporting a role for
DAI in host cell functionsmodulated by vIRA during natural infec-
tion. Interestingly, dissemination to the salivary glands (SGs) of
DAI/ mice 14 days postinfection with parental MCMV was
consistently higher than control mice (Figure S4A) regardless
of inoculation route, while mutant virus was comparably ineffi-
cient in reaching this organ.
To more directly assess the role of DAI in M45mutRHIM virus
replication patterns, control, DAI/, and RIP3/ mice were
inoculated via intraperitoneal injection. Mutant and parental virus
titers were comparable in spleen (Figure 4B) and liver (Figure 4C)
of DAI/ mice throughout acute infection, while mutant virus
was undetected in any organ at any time in control animals.
Consistent with previous findings (Upton et al., 2010), mutant
virus growth and dissemination were normalized in spleen, liver,
and SG during infection of RIP3/ animals (Figures 4B–4D, right294 Cell Host & Microbe 11, 290–297, March 15, 2012 ª2012 Elseviepanels). Mutant virus was detected in SGs of DAI/ mice (Fig-
ure 4D), albeit at levels lower than parental virus in control or
RIP3/mice. Thus, DAI deficiency permits mutant virus growth
and dissemination in vivo. Parental WT virus titers in spleen and
liver were elevated in DAI/ mice compared to C57BL/6 mice,
similar to observation following FP inoculation (Figures 4B and
4C). Mutant virus failed to replicate in highly susceptible IFNa/b
receptor (IFNAR/) knockout mice (Figure S4B), further indi-
cating that the host defense pathway controlling type I IFN is
irrelevant to virus-induced necrosis. Together, these results
provide compelling evidence that virus-induced necrosis in vivo
depends upon DAI and RIP3, and is the target of vIRA RHIM-
mediated suppression independent of the type I IFN pathway,
thereby establishing a natural function for DAI in mammalian
host defense.
DISCUSSION
In this work, we implicate the candidate cytosolic dsDNA sensor
DAI in the host response to MCMV infection, providing evidence,r Inc.
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RHIM-dependent programmed necrosis naturally suppressed
by vIRA function. We have previously shown that RIP3-depen-
dent, virus-induced programmed necrosis underlies the severe
attenuation of M45mutRHIM MCMV (Upton et al., 2010), which
is avirulent in normal or immunocompromised animals. Here,
M45mutRHIM replicates in DAI deficientmice, clearly implicating
DAI as a second player in this pathway. Other lines of evidence
have stressed that DAI is a redundant IFN-inducing DNA sensor
(Lippmann et al., 2008; Wang et al., 2008), supported by findings
that DAI is dispensable for innate or adaptive responses to
dsDNA or DNA vaccination (Ishii et al., 2008). Additionally, cyto-
solic dsDNA activates multiple PRRs to induce IFNs and activate
the inflammasome (Barber, 2011). Thus, although innate or
inflammatory pathways may be controlled by DAI, its regulation
of cell death is a critical contribution to host defense in a way that
has recently emerged in evaluation of caspase-8 as well as RIP3
(Mocarski et al., 2011). This work, with our previous observations
(Upton et al., 2010), highlights the importance of context in dis-
secting the contribution of crucial pathways in host defense.
Neither RIP3/ (Newton et al., 2004) nor DAI/ mice (Ishii
et al., 2008) exhibited outward signs of deficit until infected
with an appropriate virus.
vIRA is one of several cell death suppressors encoded by
MCMV that balance the host response to infection. The rapid
programmed necrosis characterizing vIRA mutant virus-infected
cells is likely unveiled because this mutant retains activity of at
least two additional classes of cell death suppressors: viral
inhibitor of caspase-8 activation (vICA) (McCormick et al.,
2003; Menard et al., 2003; Skaletskaya et al., 2001) and mito-
chondrial inhibitors of cell death, referred to as viral mitochon-
drial inhibitor of apoptosis (vMIA) and viral inhibitor of Bak
oligomerization (vIBO) (Cam et al., 2010; McCormick et al.,
2003, 2005). Here, we predict that vICA sensitizes virus-infected
cells to programmed necrosis by inhibiting caspase-8 activity,
which naturally holds programmed necrosis in check (Kaiser
et al., 2011; Oberst et al., 2011). Similarly, vaccinia virus B13R
encodes a caspase inhibitor that predisposes infected cells to
TNF-induced cell death (Li and Beg, 2000). In many situations,
necrotic pathways have been unveiled when caspase-8 activity
is absent or suppressed, and highlight the intricate redundancies
and crosstalk between cell death pathways. Therefore, under-
standing the function of additional MCMV cell death suppres-
sors, such as vICA, vMIA, and vIBO, in setting the stage for
vIRA-inhibited programmed necrosis will provide crucial insight
into the mechanisms initiating and executing host cell death
defenses.
The most important RHIM of DAI (also known as RLR-A or
RHIM-A) mediates direct interactions between DAI and RIP3
(Kaiser et al., 2008; Rebsamen et al., 2009) and facilitates trans-
duction of necrotic death signals (Figure 2). However, the pres-
ence of two additional RHIM-like repeats (Kaiser et al., 2008;
Rebsamen et al., 2009) raises the possibility that additional
protein-protein interactions regulate DAI activities. One current
model suggests that ligand recognition and binding induce DAI
oligomerization to drive signal transduction (Wang et al., 2008),
reminiscent of RIP1 and RIP3 oligomerization during necropto-
sis. Although our results demonstrate that one RHIM of DAI is
critical for virus-induced programmed necrosis, additionalCell HoRHIM-dependent and -independent interactions may contribute
to this pathway. Recent work showing the role of the ‘‘Ripopto-
some’’ signaling platform in necroptosis (Feoktistova et al.,
2011; Tenev et al., 2011) suggests that a DAI-RIP3 complex
may engage or coordinate a similar signaling platform to execute
virus-induced programmed necrosis. Additional studies will be
necessary to delineate the contribution of the other potential
functional DAI protein-protein interactions and motifs, including
RHIMs and DNA binding domains, during MCMV infection.
Multiple cell-type-specific pathways likely contribute to RIP3
activation (Zhang et al., 2011) and probably play a role in RIP3-
dependent necrosis in vivo. Despite restoring replication,DAI/
mice failed to completely normalize efficient dissemination of
M45mutRHIM (Figure 4D, Figure S4A), which was different
than the result in RIP3/ animals. This behavior likely reflects
the contribution of necroptosis in controlling the virus and
explains differences between M45mutRHIM phenotypes in
DAI/ and RIP3/ mice, as DAI/ mice retain both RIP3 and
RIP1 and the ability to initiate necroptoosis. In addition to
a role in cell death, DAI influences the host IFN response against
herpesviruses (DeFilippis et al., 2010a; Takaoka et al., 2007). It is
worth noting that parental MCMV reached titers 10-fold higher in
DAI/ animals compared to controls, a result that was different
from RIP3/ mice in which parental virus reached titers similar
to controls. Elimination of DAI, while normalizing M45mutRHIM
virus replication by preventing virus-induced necrosis, may
also disrupt innate or adaptive host defense pathways necessary
for efficient control of WTMCMV. Further characterization of DAI
function during MCMV infection in vivo, as well as virus-induced
signaling events leading to RIP3-dependent necrosis, will be
important future endeavors.
In summary, we have identified DAI as a critical mediator of
RIP3-dependent antiviral necrosis, providing evidence that DAI
participates in an intrinsic host cell death pathway in vitro and
in vivo. DAI expression is detected in settings where virus-
induced necrosis occurs, and expression of DAI sensitizes resis-
tant cells to this RIP3 RHIM-dependent pathway. A RIP3-DAI
complex is detected during mutant virus infection, providing
compelling evidence that modulation of this complex is critical
for viral pathogenesis. Indeed, like RIP3 (Upton et al., 2010),
loss of DAI permits vIRA-deficient viral replication in vivo,
providing formal proof that DAI participates in RIP3-dependent
antiviral necrosis. Inclusion of this PRR in the pathway of RIP3-
dependent, MCMV-induced programmed necrosis adds to our
current understanding of pathogen sensing and the intrinsic
host responses elicited by these pathways.EXPERIMENTAL PROCEDURES
Reagents and Viruses
BAC-derived parental WT K181and M45mutRHIM viruses were previously
described (Upton et al., 2010). Dimethyl sulfoxide (DMSO, Sigma-Aldrich)
and necrostatin (Nec-1, Calbiochem) were used as described (Upton et al.,
2010). Growth curves were performed as previously described (Upton et al.,
2010).
Plasmids, Transfections, and Transductions
FLAG-tagged WT andmutRLR-A DAI (Kaiser et al., 2008) were cloned into the
pQCXIH retroviral vector (Clontech). FLAG-taggedWT andmRHIMRIP3 retro-
viral and RIP3-A (TRCN0000022535), RIP3-B (TRCN0000022538), and controlst & Microbe 11, 290–297, March 15, 2012 ª2012 Elsevier Inc. 295
Cell Host & Microbe
DAI and RIP3 Control of Programmed Necrosislentiviral shRNA constructs were previously described (Upton et al., 2010).
Retro- and lentiviral production, infection, and selection were previously
described (Kaiser et al., 2008). siRNA transfections were performed with 200
pg of nontargeting, DAI, or RIP3 ON-TARGETplus SMARTpool siRNAs (Dhar-
macon) and Lipofectamine RNAiMAXX (Invitrogen) according to the manufac-
turer’s recommendations, and assays were performed 48 hr posttransfection.
Mice, Infections, and Organ Harvests
C57BL/6 mice were from Jackson Laboratory. RIP3/ mice (Ripk3tm1Vmd)
were from Genentech (Newton et al., 2004), and DAI/mice (Zbp1tm1Aki) (Ishii
et al., 2008) were from Ken Ishii (National Institute of Biomedical Innovation,
NIBIO) and Shizuo Akira (Osaka University). Infections and organ titers were
performed as previously described (Upton et al., 2010). Mice were maintained
by Emory University Division of Animal Resources, and all procedures were
approved by the Emory University Institutional Animal Care and Use
Committee.
Cell Culture and Embryonic Fibroblast Isolation
NIH 3T3 fibroblasts (ATCC CRL-1658), 3T3-SA (ATCC CCL-92), and
SVEC4-10 (ATCC CRL-2181) were maintained as previously described (Upton
et al., 2010). MEFs were isolated and maintained as previously described
(Upton et al., 2010).
Cell Viability Assays
Viability assays were performed as previously described (Upton et al., 2010)
using Cell Titer-Glo Luminescent Cell Viability Assay kit (Promega) according
to themanufacturer’s instructions. Luminescencewasmeasured on a Synergy
HT Multi-Detection microplate reader (Bio-Tek). Values are plotted as
percentage of vehicle-treated or WT-infected cells assessed in parallel with
experimental samples.
IP and IB
IP and IB analyses were performed using established methods, as previously
described (Upton et al., 2010). The following antibodies were used: mouse
anti-b-actin (clone AC-74; Sigma), mouse anti-RIP1 (clone 38; BD Biosci-
ences), anti-DAI (Karayel et al., 2009) (a gift from Tillman Burckstummer and
Giulio Superti-Furga, CeMM), anti-MCMV M45 (Lembo et al., 2004) (a gift
from David Lembo, University of Turin), rabbit anti-RIP3 (Imgenex), mouse
anti-Flag (M2 clone) horseradish peroxidase (HRP) conjugate (Sigma-Aldrich),
and anti-mouse and anti-rabbit IgG-HRP (Vector Laboratories). Immunopre-
cipitations were performed with goat anti-RIP3 (clone C-16; Santa Cruz
Biotechnology) and protein A/G agarose (Santa Cruz Biotechnology).
Statistical Methods
Comparisons were performed by one-way analysis of variance (ANOVA) with
Bonferroni’s multiple comparison tests. Unless otherwise noted, error bars
designate standard deviation (SD) of the mean.
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online at doi:10.1016/j.chom.2012.01.016.
ACKNOWLEDGMENTS
We thank Ken Ishii (NIBIO) and Shizuo Akira (Osaka University) for DAI/
mice, Vishva Dixit and Kim Newton (Genentech) for RIP3/ mice, David
Lembo (University of Turin) for anti-M45 antibody, and Tilmann Bu¨rckstu¨mmer
and Giulio Superti-Furga (CeMM) for anti-DAI antibody. This work was sup-
ported by the National Institutes of Health (NIH) (PHS grants R01 AI20211
and AI30363 to E.S.M. and F32 AI080175-01A1 to J.W.U.).
Received: October 17, 2011
Revised: December 8, 2011
Accepted: January 25, 2012
Published: March 14, 2012296 Cell Host & Microbe 11, 290–297, March 15, 2012 ª2012 ElsevieREFERENCES
Barber, G.N. (2011). Cytoplasmic DNA innate immune pathways. Immunol.
Rev. 243, 99–108.
Benedict, C.A., Angulo, A., Patterson, G., Ha, S., Huang, H., Messerle, M.,
Ware, C.F., and Ghazal, P. (2004). Neutrality of the canonical NF-kappaB-
dependent pathway for human and murine cytomegalovirus transcription
and replication in vitro. J. Virol. 78, 741–750.
Best, S.M. (2008). Viral subversion of apoptotic enzymes: escape from death
row. Annu. Rev. Microbiol. 62, 171–192.
Brune, W., Menard, C., Heesemann, J., and Koszinowski, U.H. (2001). A ribo-
nucleotide reductase homolog of cytomegalovirus and endothelial cell
tropism. Science 291, 303–305.
Burke, J.R., Pattoli, M.A., Gregor, K.R., Brassil, P.J., MacMaster, J.F.,
McIntyre, K.W., Yang, X., Iotzova, V.S., Clarke, W., Strnad, J., et al. (2003).
BMS-345541 is a highly selective inhibitor of I kappa B kinase that binds at
an allosteric site of the enzyme and blocks NF-kappa B-dependent transcrip-
tion in mice. J. Biol. Chem. 278, 1450–1456.
Cam, M., Handke, W., Picard-Maureau, M., and Brune, W. (2010).
Cytomegaloviruses inhibit Bak- and Bax-mediated apoptosis with two sepa-
rate viral proteins. Cell Death Differ. 17, 655–665.
Cho, Y.S., Challa, S., Moquin, D., Genga, R., Ray, T.D., Guildford, M., and
Chan, F.K. (2009). Phosphorylation-driven assembly of the RIP1-RIP3
complex regulates programmed necrosis and virus-induced inflammation.
Cell 137, 1112–1123.
DeFilippis, V.R., Alvarado, D., Sali, T., Rothenburg, S., and Fruh, K. (2010a).
Human cytomegalovirus induces the interferon response via the DNA sensor
ZBP1. J. Virol. 84, 585–598.
DeFilippis, V.R., Sali, T., Alvarado, D., White, L., Bresnahan, W., and Fruh, K.J.
(2010b). Activation of the interferon response by human cytomegalovirus
occurs via cytoplasmic double-stranded DNA but not glycoprotein B.
J. Virol. 84, 8913–8925.
Degterev, A., Hitomi, J., Germscheid, M., Ch’en, I.L., Korkina, O., Teng, X.,
Abbott, D., Cuny, G.D., Yuan, C., Wagner, G., et al. (2008). Identification of
RIP1 kinase as a specific cellular target of necrostatins. Nat. Chem. Biol. 4,
313–321.
Feoktistova, M., Geserick, P., Kellert, B., Dimitrova, D.P., Langlais, C., Hupe,
M., Cain, K., Macfarlane, M., Hacker, G., and Leverkus, M. (2011). cIAPs block
ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death
complex differentially regulated by cFLIP isoforms. Mol. Cell 43, 449–463.
Fu, Y., Comella, N., Tognazzi, K., Brown, L.F., Dvorak, H.F., and Kocher, O.
(1999). Cloning of DLM-1, a novel gene that is up-regulated in activatedmacro-
phages, using RNA differential display. Gene 240, 157–163.
Furr, S.R., Chauhan, V.S., Moerdyk-Schauwecker, M.J., andMarriott, I. (2011).
A role for DNA-dependent activator of interferon regulatory factor in the recog-
nition of herpes simplex virus type 1 by glial cells. J. Neuroinflammation 8, 99.
He, S., Wang, L., Miao, L., Wang, T., Du, F., Zhao, L., and Wang, X. (2009).
Receptor interacting protein kinase-3 determines cellular necrotic response
to TNF-alpha. Cell 137, 1100–1111.
He, S., Liang, Y., Shao, F., and Wang, X. (2011). Toll-like receptors activate
programmed necrosis in macrophages through a receptor-interacting
kinase-3-mediated pathway. Proc. Natl. Acad. Sci. USA 108, 20054–20059.
Hengartner, M.O. (2000). The biochemistry of apoptosis. Nature 407, 770–776.
Ishii, K.J., Kawagoe, T., Koyama, S., Matsui, K., Kumar, H., Kawai, T.,
Uematsu, S., Takeuchi, O., Takeshita, F., Coban, C., et al. (2008). TANK-
binding kinase-1 delineates innate and adaptive immune responses to DNA
vaccines. Nature 451, 725–729.
Kaiser, W.J., Upton, J.W., and Mocarski, E.S. (2008). Receptor-interacting
protein homotypic interaction motif-dependent control of NF-kappa B activa-
tion via the DNA-dependent activator of IFN regulatory factors. J. Immunol.
181, 6427–6434.
Kaiser, W.J., Upton, J.W., Long, A.B., Livingston-Rosanoff, D., Daley-Bauer,
L.P., Hakem, R., Caspary, T., and Mocarski, E.S. (2011). RIP3 mediates the
embryonic lethality of caspase-8-deficient mice. Nature 471, 368–372.r Inc.
Cell Host & Microbe
DAI and RIP3 Control of Programmed NecrosisKarayel, E., Burckstummer, T., Bilban, M., Durnberger, G., Weitzer, S.,
Martinez, J., and Superti-Furga, G. (2009). The TLR-independent DNA recog-
nition pathway in murine macrophages: ligand features and molecular signa-
ture. Eur. J. Immunol. 39, 1929–1936.
Katdare, M., Efimova, E.V., Labay, E., Khodarev, N.N., Darga, T.E., Garofalo,
M., Nakamura, S., Kufe, D.W., Posner, M.C., and Weichselbaum, R.R.
(2007). Diverse TNFalpha-induced death pathways are enhanced by inhibition
of NF-kappaB. Int. J. Oncol. 31, 1519–1528.
Lamkanfi, M., and Dixit, V.M. (2010). Manipulation of host cell death pathways
during microbial infections. Cell Host Microbe 8, 44–54.
Lembo, D., Donalisio, M., Hofer, A., Cornaglia, M., Brune, W., Koszinowski, U.,
Thelander, L., and Landolfo, S. (2004). The ribonucleotide reductase R1
homolog of murine cytomegalovirus is not a functional enzyme subunit but is
required for pathogenesis. J. Virol. 78, 4278–4288.
Li, M., and Beg, A.A. (2000). Induction of necrotic-like cell death by tumor
necrosis factor alpha and caspase inhibitors: novel mechanism for killing
virus-infected cells. J. Virol. 74, 7470–7477.
Lippmann, J., Rothenburg, S., Deigendesch, N., Eitel, J., Meixenberger, K.,
van Laak, V., Slevogt, H., N’Guessan, P.D., Hippenstiel, S., Chakraborty, T.,
et al. (2008). IFNbeta responses induced by intracellular bacteria or cytosolic
DNA in different human cells do not require ZBP1 (DLM-1/DAI). Cell.
Microbiol. 10, 2579–2588.
Mack, C., Sickmann, A., Lembo, D., and Brune, W. (2008). Inhibition of proin-
flammatory and innate immune signaling pathways by a cytomegalovirus
RIP1-interacting protein. Proc. Natl. Acad. Sci. USA 105, 3094–3099.
McCormick, A.L., Skaletskaya, A., Barry, P.A., Mocarski, E.S., and
Goldmacher, V.S. (2003). Differential function and expression of the viral inhib-
itor of caspase 8-induced apoptosis (vICA) and the viral mitochondria-local-
ized inhibitor of apoptosis (vMIA) cell death suppressors conserved in primate
and rodent cytomegaloviruses. Virology 316, 221–233.
McCormick, A.L., Meiering, C.D., Smith, G.B., and Mocarski, E.S. (2005).
Mitochondrial cell death suppressors carried by human and murine cytomeg-
alovirus confer resistance to proteasome inhibitor-induced apoptosis. J. Virol.
79, 12205–12217.
Menard, C.,Wagner, M., Ruzsics, Z., Holak, K., Brune,W., Campbell, A.E., and
Koszinowski, U.H. (2003). Role of murine cytomegalovirus US22 gene family
members in replication in macrophages. J. Virol. 77, 5557–5570.
Mocarski, E.S., Upton, J.W., and Kaiser, W.J. (2011). Viral infection and the
evolution of caspase 8-regulated apoptotic and necrotic death pathways.
Nat. Rev. Immunol. 12, 79–88.
Newton, K., Sun, X., and Dixit, V.M. (2004). Kinase RIP3 is dispensable for
normal NF-kappa Bs, signaling by the B-cell and T-cell receptors, tumor
necrosis factor receptor 1, and Toll-like receptors 2 and 4. Mol. Cell. Biol.
24, 1464–1469.Cell HoOberst, A., Dillon, C.P., Weinlich, R., McCormick, L.L., Fitzgerald, P., Pop, C.,
Hakem, R., Salvesen, G.S., and Green, D.R. (2011). Catalytic activity of the
caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature 47,
363–367.
Rebsamen, M., Heinz, L.X., Meylan, E., Michallet, M.C., Schroder, K.,
Hofmann, K., Vazquez, J., Benedict, C.A., and Tschopp, J. (2009). DAI/ZBP1
recruits RIP1 and RIP3 through RIP homotypic interaction motifs to activate
NF-kappaB. EMBO Rep. 10, 916–922.
Skaletskaya, A., Bartle, L.M., Chittenden, T., McCormick, A.L., Mocarski, E.S.,
and Goldmacher, V.S. (2001). A cytomegalovirus-encoded inhibitor of
apoptosis that suppresses caspase-8 activation. Proc. Natl. Acad. Sci. USA
98, 7829–7834.
Strasser, A., O’Connor, L., and Dixit, V.M. (2000). Apoptosis signaling. Annu.
Rev. Biochem. 69, 217–245.
Takaoka, A., Wang, Z., Choi, M.K., Yanai, H., Negishi, H., Ban, T., Lu, Y.,
Miyagishi, M., Kodama, T., Honda, K., et al. (2007). DAI (DLM-1/ZBP1) is
a cytosolic DNA sensor and an activator of innate immune response. Nature
448, 501–505.
Tenev, T., Bianchi, K., Darding, M., Broemer, M., Langlais, C., Wallberg, F.,
Zachariou, A., Lopez, J., Macfarlane, M., Cain, K., et al. (2011). The ripopto-
some, a signaling platform that assembles in response to genotoxic stress
and loss of IAPs. Mol. Cell 43, 432–448.
Upton, J.W., Kaiser, W.J., and Mocarski, E.S. (2008). Cytomegalovirus M45
cell death suppression requires receptor-interacting protein (RIP) homotypic
interaction motif (RHIM)-dependent interaction with RIP1. J. Biol. Chem.
283, 16966–16970.
Upton, J.W., Kaiser, W.J., and Mocarski, E.S. (2010). Virus inhibition of RIP3-
dependent necrosis. Cell Host Microbe 7, 302–313.
Vanden Berghe, T., Kalai, M., Denecker, G., Meeus, A., Saelens, X., and
Vandenabeele, P. (2006). Necrosis is associated with IL-6 production but
apoptosis is not. Cell. Signal. 18, 328–335.
Wang, Z., Choi, M.K., Ban, T., Yanai, H., Negishi, H., Lu, Y., Tamura, T.,
Takaoka, A., Nishikura, K., and Taniguchi, T. (2008). Regulation of innate
immune responses by DAI (DLM-1/ZBP1) and other DNA-sensing molecules.
Proc. Natl. Acad. Sci. USA 105, 5477–5482.
Zhang, D.W., Shao, J., Lin, J., Zhang, N., Lu, B.J., Lin, S.C., Dong, M.Q., and
Han, J. (2009). RIP3, an energy metabolism regulator that switches TNF-
induced cell death from apoptosis to necrosis. Science 325, 332–336.
Zhang, D.W., Zheng, M., Zhao, J., Li, Y.Y., Huang, Z., Li, Z., and Han, J. (2011).
Multiple death pathways in TNF-treated fibroblasts: RIP3- and RIP1-depen-
dent and independent routes. Cell Res. 21, 368–371.st & Microbe 11, 290–297, March 15, 2012 ª2012 Elsevier Inc. 297
